USANA Health Sciences Inc. (NASDAQ:USNA) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company.
USANA Health Sciences Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased 54.95% to $1.72 in the quarter versus EPS of $1.11 in the year-earlier quarter.
Revenue: Rose 17.53% to $189.1 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: USANA Health Sciences Inc. reported adjusted EPS income of $1.72 per share. By that measure, the company beat the mean analyst estimate of $1.33. It beat the average revenue estimate of $176.4 million.
Quoting Management: “Our team continues to effectively execute our strategic initiatives, which led to another record quarter,” said Dave Wentz, the Company’s Chief Executive Officer. “Our financial performance was driven by sales and customer growth in both our Asia Pacific and North America regions. Additionally, during the quarter we implemented a worldwide policy that focuses on customers purchasing products in their home market. This policy, which strengthens the Company’s business long-term, led to an estimated $7 million in one-time incremental sales that contributed to the quarter’s exceptional results. While we expect this policy to create pressure on our results in the near term, we believe that it is in the best interest of USANA’s long-term business.”
Key Stats (on next page)…
Revenue increased 11.84% from $169.08 million in the previous quarter. EPS increased 34.38% from $1.28 in the previous quarter.
Looking Forward: Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $1.32 to a profit $1.33. For the current year, the average estimate has moved up from a profit of $5.31 to a profit of $5.36 over the last ninety days.